Unitree Raises $904M as China's First Humanoid IPO

The most profitable humanoid robot company on Earth is going public, and it is doing so in defiance of a geopolitical environment designed to stop it. On August 6, 2026, Unitree Robotics priced its initial public offering on Shanghai's STAR Market at 150.80 yuan per share, seeking to raise approximately 6.1 billion yuan ($904 million), a figure that would make it China's first mainland publicly traded humanoid robot maker. The timing is deliberate: Unitree confirmed its IPO launch less than two days after the United States finalized measures targeting Chinese robotics firms, a sequence that says as much about where global power in humanoid robotics is shifting as any benchmark score or production milestone could.

What Actually Happened

According to Bloomberg, Unitree is selling 40.4464 million new shares representing 10% of its total share capital at 150.80 yuan each, implying a base market capitalization of roughly 61 billion yuan ($9 billion) at the offering price. The lead underwriter is CITIC Securities. The issuance uses a combination of strategic placement, offline institutional subscription, and online retail subscription, with the online roadshow taking place on August 7, 2026, hosted by CITIC from 14:00 to 17:00, featuring Unitree chairman Wang Xingxing and senior management. Wang Xingxing is personally subscribing for 15 million yuan of the strategic placement, and Unitree's core management team is participating through two asset management plans capped at 271.5 million yuan combined, a commitment structure that aligns insider incentives with public shareholders at launch.

The company's financial profile is what separates this IPO from the wave of no-revenue robotics listings investors have seen from Western peers. Per Gasgoo, Unitree reported annual revenue of approximately 1.71 billion yuan ($235 million) in 2025, representing 335% year-over-year growth. Gross margins reached nearly 60% by the end of that year, up from the mid-40% range in 2022 and 2023, driven by a product mix shift toward higher-value humanoid systems from the G1 and H1 families that carry better margin profiles by 15 or more percentage points than the company's quadruped robots. The company shipped more than 5,500 humanoid robots in 2025, more than any other company globally by volume, and holds more than 60% global market share in quadruped robotics. In an industry where the dominant narrative involves companies burning capital to demonstrate future commercial potential, Unitree is already running a profitable business.

The regulatory backdrop for this listing is striking. As Seoul Economic Daily reported, Unitree formalized its STAR Market IPO process just two days after the United States finalized import restrictions on Chinese humanoid and quadruped robots. The Federal Communications Commission's July 2026 action specifically cited confirmed security vulnerabilities in Unitree hardware, including CVE-2025-2894, a backdoor service called CloudSail embedded in the Unitree Go1 firmware that allows remote access without user authorization. The Pentagon had separately designated Unitree a Chinese military company in June 2026, barring it from US defense contracts. Proceeding with a $904 million public listing in this environment is not an oversight or an act of defiance in the provocative sense. It is a declaration that Unitree's business does not depend on US market access to justify a multi-billion dollar valuation.

Why This Matters More Than People Think

The contrast between Unitree's financial profile and that of its Western competitor Figure AI crystallizes what the humanoid robot industry's valuation debate is actually about. Figure AI, the American humanoid robotics startup that counts BMW and OpenAI among its partners, was valued at approximately $39 billion in its most recent funding round despite having essentially no revenue from robot sales at commercial scale. Unitree, by contrast, is approaching its IPO with $235 million in annual revenue, 60% gross margins, 5,500-plus units shipped, and a path to profitability that does not require a 10-year wait for mass deployment. The $9 billion IPO valuation implies a forward price-to-sales multiple of roughly 30 to 40 times based on 2025 revenue, elevated by any traditional measure, but defensible as a growth multiple for a company posting 335% year-over-year topline expansion with improving unit economics. The market is being asked to choose between a cash-generating machine with a modest valuation and a vision company with an enormous one, and both paths have historical precedent in technology.

The practical implications of the US FCC import ban deserve serious attention. Unitree launched commercially in Western markets on July 22, 2026, becoming the first Chinese-made humanoid robot to enter commercial sale in Europe. That launch occurred just six days before the FCC action, which means Unitree's European commercial foothold may represent the company's only available Western distribution channel for newly introduced models. The US market is effectively closed to new Unitree hardware, and any US customers who purchased FCC-authorized products before the action retain them, but the growth trajectory in North America is now capped. This is a material constraint: the United States represents the world's single largest commercial robotics market by deployment spending, and a company that cannot access it faces a structural ceiling on its total addressable market that its public offering documents will need to address honestly. Per KraneShares, secondary market expectations for Unitree's post-listing price have been anchored above 100 billion yuan ($14.8 billion), implying the market already discounts the US ban's impact as manageable against Unitree's domestic Chinese and European growth trajectories.

China's domestic market context is what makes that optimism defensible rather than delusional. The Chinese government has designated humanoid robotics a strategic national priority, with targeted production volumes of 100,000 units by 2025 and trajectory toward 1 million units by 2028 embedded in multiple provincial industrial policy plans. BYD, the world's largest electric vehicle company by sales volume, confirmed in late July that it is entering the humanoid robot market with an early August 2026 debut at its Di Space showrooms, positioning its manufacturing infrastructure and battery expertise as competitive advantages. AgiBot, which has shipped 15,000 cumulative humanoid units, has simultaneously announced it is pursuing a Hong Kong Stock Exchange listing. The domestic humanoid market Unitree is seeking to serve is being defined right now, by multiple well-capitalized Chinese companies competing aggressively, with government procurement and industrial deployment demand as the primary near-term revenue pools.

The Competitive Landscape

Unitree occupies an unusual position in the global humanoid robot competitive landscape: it is simultaneously the only humanoid robot maker with proven profitability and unit economics, the company most directly targeted by US regulatory actions, and the first to reach public market status on a major exchange. Its closest Chinese competitor, AgiBot, has shipped more total units (15,000 versus Unitree's 5,500 humanoids specifically) but is not yet public and is pursuing the Hong Kong market rather than the STAR Market. Fourier Intelligence, another Chinese humanoid maker, focuses more heavily on rehabilitation robotics than commercial deployment. Boston Dynamics, the American robotics company owned by Hyundai, remains private and continues its transition from research-focused demos toward Atlas commercial deployment, with no revenue figures remotely comparable to Unitree's 2025 numbers. The competitive moat Unitree has built through vertical supply chain integration, domestic component sourcing above 90%, and iterative hardware design across both quadruped and humanoid platforms is real and not easily replicated at speed.

The historical parallel that best illuminates Unitree's position is DJI, the Chinese drone manufacturer that built a dominant global market share in consumer and commercial drones before facing US regulatory targeting beginning in 2020. DJI, like Unitree, had products with genuine technical superiority in their category, a cost structure enabled by deep Chinese supply chain integration, and a domestic market that continued expanding despite Western restrictions. DJI's response to US pressure was to double down on non-US markets, expand aggressively in Southeast Asia, Europe, and Latin America, and invest in enterprise use cases that reduced consumer-channel dependence. Unitree appears to be executing a similar playbook: the European commercial launch, the BMW logistics partnership through Figure (a competitor, not a partner, which reveals how the industry's supply chains work in practice), and the focus on industrial and research customers who can acquire without the same regulatory scrutiny as military or government buyers.

The bear case, however, is that the US market exclusion matters more than the DJI parallel suggests. Drone regulation primarily affected consumer hobbyists and smaller commercial operators who could often use alternatives. Humanoid robots for industrial deployment in US manufacturing facilities, logistics operations, and eventually retail environments represent a market that simply will not be available to Unitree without a fundamental change in US-China technology policy. The risk is not just lost revenue from US customers directly. It is the compounding effect of being excluded from the market that sets global robotics standards, trains the most advanced deployment workflows, and generates the use-case data that feeds next-generation robot training. Skeptics argue that a company cut off from the US industrial base will fall further behind on real-world deployment diversity even if it maintains hardware volume leadership.

Hidden Insight: Why the 60% Gross Margin Changes Everything

The single most important number in Unitree's IPO filing is not the $904 million raise, the 335% revenue growth rate, or the 5,500 units shipped. It is the 60% gross margin. That figure, if sustained, implies that Unitree has solved unit economics for humanoid robots in a way no Western competitor has come close to demonstrating. Figure AI, Boston Dynamics Atlas, and Agility Robotics all operate at negative gross margins: each robot sold costs more to build than it sells for, with the hope that scale and manufacturing learning curves will eventually close the gap. Unitree is already past that gap. A 60% gross margin in hardware at this scale suggests deep vertical integration, mature supply chain management, and a cost reduction program that has survived real commercial deployment, not lab conditions. It means Unitree can invest in R&D, expand sales channels, and weather price competition while still being profitable, a combination that defines durable competitive advantage.

The 335% year-over-year revenue growth figure deserves equal attention, particularly in the context of H1 2026 performance. Per BigGo Finance, Unitree's first-half 2026 revenue growth dropped to approximately 40% from the prior year's 335% pace. This deceleration is either a natural normalization after a breakout year, a consequence of the US regulatory actions reducing addressable demand, or an early sign that Unitree's initial customer base has been largely penetrated and new use cases are slower to adopt. The IPO prospectus timing means retail investors will be buying into the company with visibility into this deceleration but without a clear forward view on whether the 40% growth rate stabilizes, rebounds, or continues declining as Western markets close further. This is the central financial uncertainty the offering must address, and it is the data point that sophisticated institutional investors will weight most heavily in their subscription decisions.

Wang Xingxing's decision to personally subscribe for 15 million yuan of the strategic placement, and to have management teams commit up to 271.5 million yuan total, is a stronger insider confidence signal than most IPO documents contain. These are not token amounts. At a total offering size of 6.1 billion yuan, the management subscription represents roughly 4.7% of the total raise, more than double the typical insider participation ratios in STAR Market listings. This signals that the people closest to Unitree's actual performance trajectory believe the IPO price understates the company's value, a belief that would be difficult to maintain if they had visibility into fundamental deterioration in the business. It also creates a structural alignment between management and new public shareholders that is notably absent from many high-profile Western tech IPOs, where insider lockups and secondary share sales often send the opposite signal.

The deeper question the Unitree IPO raises is what happens to the humanoid robot industry's valuation framework when a profitable, high-growth player at the frontier reaches public markets. For the past three years, humanoid robotics valuations have been set primarily by venture rounds in private companies that could tell any story about total addressable market without being held accountable to financial results. Figure AI's $39 billion valuation is sustained by investor belief in a deployment vision that generates essentially no revenue today. Unitree's public listing introduces a mark-to-market reference point that will influence how every private humanoid robot company is valued in subsequent funding rounds. If Unitree trades at 30 times revenue and posts 40% growth, that multiple becomes a ceiling for companies with less revenue and lower growth, not a floor. The IPO does not just matter for Unitree shareholders. It recalibrates the entire industry's valuation landscape.

What to Watch Next

In the next 30 days, the critical event is the Unitree subscription opening on August 10 and the trading debut on the STAR Market. Oversubscription ratios in Chinese IPOs of this profile typically range from 50 to 500 times for institutional tranches, and the magnitude of oversubscription will be the first market signal about whether investors accept the company's growth narrative despite the US ban and the H1 2026 deceleration. A trading debut above 200 yuan per share (a roughly 33% premium to the 150.80 yuan offering price) would confirm strong market appetite. A debut below 170 yuan would signal skepticism about the H1 2026 revenue trajectory. Watch also for BYD's humanoid robot debut at Di Space showrooms in Zhengzhou, which is happening in the same week and will either reinforce or dilute Unitree's positioning as the category leader.

At 90 days, the key indicator is Unitree's H2 2026 revenue trajectory, which will be visible in the company's first quarterly filing as a public company. If revenue growth reaccelerates from the 40% H1 pace toward the 100% or higher range as new industrial deployment contracts materialize, the IPO valuation will look conservative in hindsight. If growth remains at 40% or decelerates further, the $9 billion IPO valuation will come under pressure in secondary markets. Equally important is the progress of AgiBot's Hong Kong listing: if AgiBot's offering prices at a higher revenue multiple than Unitree's STAR Market valuation, it will create an arbitrage conversation that benefits Unitree shareholders. If AgiBot prices at a discount, it will raise questions about whether the sector is overvalued at every level of the capital stack.

At 180 days, the question is whether Unitree's European commercial presence expands materially or stalls against safety certification barriers and procurement timelines. The July 22 European launch gave Unitree a commercial foothold in the one Western market that remains accessible, but converting that foothold into real revenue requires navigating EU machinery regulations, CE marking requirements, and enterprise procurement cycles that can run 12 to 18 months. If Unitree closes 10 or more European industrial deployment contracts by February 2027, the Western market thesis recovers meaningfully despite US closure. If European revenue remains negligible, the investment case rests entirely on China domestic growth and the geopolitical durability of that market access in a period of intensifying technology decoupling between the US and Chinese ecosystems.

Unitree is the first humanoid robot company to prove the unit economics work, and the first to have that proof tested by public markets while the world's largest economy is trying to lock it out.

---